Creative Diagnostics introduces comprehensive Vaccine Development CRO Services. NEW YORK, NY, UNITED STATES, February 22, 2025 /EINPresswir ...
Creative Diagnostics announces the launch of its new Norovirus VP1 VLP Panel to support NoV research. NEW YORK, NY, UNITED STATES, February ...
In a Community Case Forum in partnership with the North Carolina Oncology Association, Cristina Gasparetto, MD, discussed the CEPHEUS, IMROZ, and BENEFIT trials of treatment for transplant-ineligible ...
Combining an existing small-molecule protein therapy called tumor necrosis factor related apoptosis-inducing ligand (TRAIL) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results